TMS denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for tms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied TMS Under Step Therapy — and How to Fight It

Transcranial Magnetic Stimulation (TMS) is cleared by the FDA as a treatment for depression and related conditions, but UnitedHealthcare classifies it as a step-therapy item — meaning the plan requires documented failure of one or more lower-cost or lower-intensity treatments before it will authorize TMS. A step-therapy denial means the plan believes you have not yet completed the required treatment steps, or that proof of those prior failures was not included in the authorization request.

This is one of the most straightforwardly appealable denial types. Step-therapy requirements are procedural gates; if your medical record already documents the required prior treatments and their outcomes, the denial can often be reversed at the internal appeal level simply by providing that documentation in an organized format.

## Federal Appeal Rights

• Internal appeal: File within the deadline on your denial notice. For non-urgent cases the plan has 30 days to decide; for concurrent/urgent care, 72 hours. Request the full file used to make the denial decision — you are entitled to it.
• Step-therapy override laws: Many states have enacted step-therapy override statutes requiring insurers to grant exceptions when the required prior therapy is clinically contraindicated, has already been tried and failed, or when delay would cause serious harm. Check whether your state's law applies to your plan type (fully-insured vs. self-funded).
• External review (ACA §2719 / ERISA §503): If internal appeal fails, you may escalate to an independent review organization within approximately four months of the final internal denial. Expedited review is available for urgent clinical situations.

## What to Gather

• Diagnosis documentation: Formal diagnosis supporting the TMS indication, from chart notes and any relevant specialist evaluation.
• Prior treatment timeline: A chronological list of every medication or therapy tried, with start and end dates, dosage escalation history, and the documented clinical reason each was stopped or deemed inadequate — failure, intolerable side effects, contraindication.
• Prescriber attestation: A letter from your psychiatrist or treating physician explicitly stating which step-therapy requirements have been met, with chart citations for each.
• Clinical severity: Current symptom documentation, validated rating scales, and functional-impairment notes demonstrating the urgency of moving to TMS.
• Contraindication or exception basis (if applicable): If any required prior step was skipped because it was contraindicated or unsafe for you specifically, document that clinical reasoning clearly.

## Criteria-Mapping Structure

Download UnitedHealthcare's published Coverage Determination Guideline for TMS. Identify every step in the required treatment sequence. For each step, produce a one-line response citing the specific chart date, provider, treatment tried, and documented outcome. If your record shows you completed more steps than required, list all of them. If any step was skipped for a documented clinical reason, quote that reason and cite the note. This structured mapping turns your appeal into an easy checklist review for the appeals clinician.